Still A COVID-19 Game Changer? UK’s Cautious Launch Of MSD’s Antiviral Lagevrio
Efficacy In Vaccinated Population Unproven
The Lagevrio study coincides with the UK re-introducing social distancing measures to limit the effects of the new Omicron variant. • Source: Getty Images
